胰腺导管内嗜酸性乳头状瘤的临床病理学特征（附5例报告）

doi:10.16139/j.1007-9610.2022.01.013

摘要/Abstract

摘要：

目的:探讨胰腺导管内嗜酸性乳头状瘤（pancreatic intraductal oncocytic papillary neoplasm,IOPN）的临床病理学特征。方法:我院5例IOPN,女 3 例,男2例,年龄（60.0±10.4）岁。分析临床特征、肿瘤大体和镜下表现特点、免疫表型及预后。结果:2例伴腹部隐痛,其中1例半年内体重减轻5 kg。3例体检发现。胰腺肿瘤位于头部2例,位于头体部、颈部、体部各1例。1例血清CA724升高,其他血清学指标均正常。肿瘤呈多房囊性、囊实性或实性。实性区灰白色、质脆,囊内壁光滑或伴乳头样突起。镜下见导管内生长,囊内具有复杂的分支乳头状结构。乳头衬覆的肿瘤细胞胞质丰富,富含嗜酸性颗粒。细胞异型性大,核仁明显。肿瘤细胞间可见杯状细胞,黏液分泌不显著。免疫组织化学结果为,细胞角蛋白7阳性（3/4）,MUC1、MUC6阳性（4/4）,MUC5AC阳性（3/3）,肝细胞抗原Hep Par 1阳性（3/4）。个别肿瘤细胞CK20或MUC2阳性,SYN及CgA阴性（2/2）。其中4例获得随访,均无复发及转移。结论:IOPN是较罕见的胰腺低度恶性上皮性肿瘤。IOPN从胰腺导管内乳头状黏液瘤中分离出来,具有独特的临床及病理学特点。由于IOPN罕见,需进一步研究和加强认识。

关键词: 胰腺, 导管内嗜酸性乳头状瘤, 病理学, 免疫组织化学

Abstract:

Objective To analyze the clinicopathological features of pancreatic intraductal oncocytic papillary neoplasm (IOPN). Methods Five cases with pancreatic IOPN were in Ruijin Hospital including 3 female and 2 male, and the average age (60.0±10.4) years old. The clinical features combined with gross and microscopic pathology, immunophenotype and prognosis were analyzed. Results Two cases had abdominal pain including 1 case losing 5 kg during the period of 6 months. Three patients were found on physical examination. Pancreatic tumor in 2 cases located at the head, in 3 cases at the head and the body, the neck, and the body, respectively. The test showed serological CA724 elevated in 1 case, and other serological indexes were normal. The gross pathology showed that the tumor was multilocular cystic, cystic solid or solid. The solid area was gray-white, fragile, and the inner wall of the cyst was smooth or with papillary protrusions. The microscopic pathology showed that the tumor was ductal growth with complex branched papillary structure in the capsule. The tumor cells lining the papilla had eosinophilic granules, and the cell was atypia and contained typical nucleolus. Goblet cells could be seen among tumor cells. Mucus secretion was present and without significance. Immunohistochemistry showed cytokeratin 7 positive (3/4), MUC1 and MUC6 positive (4/4), MUC5AC positive (3/3), hepatocyte antigen (Hep Par 1) positive (3/4). CK20 or MUC2 in individual tumor cells were positive and SYN and CgA negative (2/2). There were 4 cased with following-up without recurrence or metastasis in any case. Conclusions IOPN is a rare pancreatic epithelial tumor with low malignancy, which is divided from pancreatic intraductal papillary mucinous neoplasms, and has unique clinical and pathological characteristics. Further study with recognition is needed for rare disease of IOPN.

Key words: Pancreas, Intraductal oncocytic papillary neoplasm, Pathology, Immunohistochemistry

中图分类号:

R735.9

杨春雪, 许海敏, 笪倩. 胰腺导管内嗜酸性乳头状瘤的临床病理学特征（附5例报告）[J]. 外科理论与实践, 2022, 27(01): 52-57.

YANG Chunxue, XU Haimin, DA Qian. Clinicopathological features of pancreatic intraductal oncocytic papillary neoplasm: a report of 5 cases[J]. Journal of Surgery Concepts & Practice, 2022, 27(01): 52-57.

图/表 4

表1

图1

图2

表2

参考文献 22

[1]	Adsay NV, Adair CF, Heffess CS, et al. Intraductal oncocytic papillary neoplasms of the pancreas[J]. Am J Surg Pathol, 1996, 20(8):980-994. pmid: 8712298
[2]	Basturk O, Tan M, Bhanot U, et al. The oncocytic subtype is genetically distinct from other pancreatic intraductal papillary mucinous neoplasm subtypes[J]. Mod Pathol, 2016, 29(9):1058-1069. doi: 10.1038/modpathol.2016.98 URL
[3]	D′Onofrio M, de Robertis R, Tinazzi Martini P, et al. Oncocytic intraductal papillary mucinous neoplasms of the pancreas: imaging and histopathological findings[J]. Pancreas, 2016, 45(9):1233-1242. doi: 10.1097/MPA.0000000000000676 URL
[4]	Wang T, Askan G, Adsay V, et al. Intraductal oncocytic papillary neoplasms: clinical-pathologic characterization of 24 cases, with an emphasis on associated invasive carcinomas[J]. Am J Surg Pathol, 2019, 43(5):656-661. doi: 10.1097/PAS.0000000000001226 pmid: 30986801
[5]	Kallen ME, Naini BV. Intraductal oncocytic papillary neoplasms of the pancreas[J]. Arch Pathol Lab Med, 2016, 140(9):992-996. doi: 10.5858/arpa.2014-0595-RS URL
[6]	Liszka L, Pajak J, Zielińska-Pajak E, et al. Intraductal oncocytic papillary neoplasms of the pancreas and bile ducts: a description of five new cases and review based on a systematic survey of the literature[J]. J Hepatobiliary Pancreat Sci, 2010, 17(3):246-261. doi: 10.1007/s00534-010-0268-2 URL
[7]	Furukawa T, Hatori T, Fujita I, et al. Prognostic relevance of morphological types of intraductal papillary mucinous neoplasms of the pancreas[J]. Gut, 2011, 60(4):509-516. doi: 10.1136/gut.2010.210567 pmid: 21193453
[8]	Klöppel G, Basturk O, Schlitter AM, et al. Intraductal neoplasms of the pancreas[J]. Semin Diagn Pathol, 2014, 31(6):452-466. doi: S0740-2570(14)00079-3 pmid: 25282472
[9]	Patel SA, Adams R, Goldstein M, et al. Genetic analysis of invasive carcinoma arising in intraductal oncocytic papillary neoplasm of the pancreas[J]. Am J Surg Pathol, 2002, 26(8):1071-1077. doi: 10.1097/00000478-200208000-00014 URL
[10]	Adsay NV, Longnecker DS, Klimstra DS. Pancreatic tumors with cystic dilatation of the ducts: intraductal pa-pillary mucinous neoplasms and intraductal oncocytic papillary neoplasms[J]. Semin Diagn Pathol, 2000, 17(1):16-30. pmid: 10721804
[11]	Kang MJ, Lee KB, Jang JY, et al. Evaluation of clinical meaning of histological subtypes of intraductal papillary mucinous neoplasm of the pancreas[J]. Pancreas, 2013, 42(6):959-966. doi: 10.1097/MPA.0b013e31827cddbc URL
[12]	Grützmann R, Niedergethmann M, Pilarsky C, et al. Intraductal papillary mucinous tumors of the pancreas: biology, diagnosis, and treatment[J]. Oncologist, 2010, 15(12):1294-1309. doi: 10.1634/theoncologist.2010-0151 pmid: 21147870
[13]	Terris B, Dubois S, Buisine MP, et al. Mucin gene expression in intraductal papillary-mucinous pancreatic tumours and related lesions[J]. J Pathol, 2002, 197(5):632-637. doi: 10.1002/path.1146 URL
[14]	Basturk O, Chung SM, Hruban RH, et al. Distinct pathways of pathogenesis of intraductal oncocytic papillary neoplasms and intraductal papillary mucinous neoplasms of the pancreas[J]. Virchows Arch, 2016, 469(5):523-532. doi: 10.1007/s00428-016-2014-x URL
[15]	Welter C, Kovacs G, Seitz G, et al. Alteration of mitochondrial DNA in human oncocytomas[J]. Genes Chromosomes Cancer, 1989, 1(1):79-82. doi: 10.1002/gcc.2870010112 URL
[16]	Mattiolo P, Hong SM, Paolino G, et al. CD117 is a specific marker of intraductal papillary mucinous neoplasms (IPMN) of the pancreas, oncocytic subtype[J]. Int J Mol Sci, 2020, 21(16):5794. doi: 10.3390/ijms21165794 URL
[17]	Schönleben F, Qiu W, Bruckman KC, et al. BRAF and KRAS gene mutations in intraductal papillary mucinous neoplasm/carcinoma(IPMN/IPMC) of the pancreas[J]. Cancer Lett, 2007, 249(2):242-248. pmid: 17097223
[18]	Furukawa T, Kuboki Y, Tanji E, et al. Whole-exome sequencing uncovers frequent GNAS mutations in intraduc-tal papillary mucinous neoplasms of the pancreas[J]. Sci Rep, 2011, 1:161. doi: 10.1038/srep00161 pmid: 22355676
[19]	Amato E, Molin MD, Mafficini A, et al. Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas[J]. J Pathol, 2014, 233(3):217-227. doi: 10.1002/path.4344 URL
[20]	Kuboki Y, Shimizu K, Hatori T, et al. Molecular biomar-kers for progression of intraductal papillary mucinous neo-plasm of the pancreas[J]. Pancreas, 2015, 44(2):227-235. doi: 10.1097/MPA.0000000000000253 URL
[21]	Singhi AD, Wood LD, Parks E, et al. Recurrent rearrangements in PRKACA and PRKACB in intraductal oncocytic papillary neoplasms of the pancreas and bile duct[J]. Gastroenterology, 2020, 158(3):573-582.e572. doi: S0016-5085(19)41481-9 pmid: 31678302
[22]	Muraki T, Uehara T, Sano K, et al. A case of MUC5AC-positive intraductal neoplasm of the pancreas classified as an intraductal tubulopapillary neoplasm?[J]. Pathol Res Pract, 2015, 211(12):1034-1039. doi: 10.1016/j.prp.2015.10.009 URL